CAPANO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 665
EU - Europa 358
AS - Asia 176
AF - Africa 9
Totale 1.208
Nazione #
US - Stati Uniti d'America 660
CN - Cina 102
IT - Italia 96
SE - Svezia 63
IE - Irlanda 57
FR - Francia 34
FI - Finlandia 28
SG - Singapore 24
GB - Regno Unito 18
PL - Polonia 17
UA - Ucraina 14
VN - Vietnam 14
DE - Germania 12
IN - India 11
KR - Corea 11
BE - Belgio 10
SN - Senegal 9
CA - Canada 4
ES - Italia 2
IQ - Iraq 2
IR - Iran 2
JP - Giappone 2
NL - Olanda 2
NO - Norvegia 2
SA - Arabia Saudita 2
CH - Svizzera 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.208
Città #
Chandler 118
Ann Arbor 78
Dublin 57
Torino 53
Beijing 52
Houston 34
Fairfield 33
Ashburn 31
Nyköping 31
Dearborn 27
Villeurbanne 27
Woodbridge 25
Medford 18
Princeton 18
Pisa 16
Warsaw 16
Wilmington 15
Singapore 13
Fremont 12
Seattle 12
Brussels 10
Cambridge 10
Dong Ket 10
Jacksonville 10
Boardman 7
Guangzhou 7
Hefei 7
Hangzhou 5
Los Angeles 4
Milan 4
Norwalk 4
Redwood City 4
San Diego 4
Xian 4
Boston 3
Nanjing 3
Patna 3
San Francisco 3
Al Hillah 2
Changsha 2
Chengdu 2
Helsinki 2
Hyderabad 2
Jeddah 2
Jinan 2
Kunming 2
Montreal 2
New York 2
Oslo 2
Pune 2
Romainville 2
Rome 2
Shanghai 2
Turin 2
Alexandria 1
Amsterdam 1
Arvada 1
Bangkok 1
Baotou 1
Buffalo 1
Castelletto Sopra Ticino 1
Central District 1
Chions 1
Chongqing 1
Dallas 1
Edmonton 1
Eitensheim 1
Garza García 1
Guiyang 1
Harbin 1
Hebei 1
Horia 1
Jakarta 1
Jinhua 1
Johor Bahru 1
Kagoshima 1
Kiel 1
Leiden 1
Lexington 1
Luni 1
Manchester 1
Mountain View 1
Muenster 1
Nashville 1
Nottingham 1
Phoenix 1
Piossasco 1
Pécs 1
Québec 1
Raleigh 1
Rzeszów 1
Saarbrücken 1
Sanayi 1
Sassari 1
Taipei 1
Tappahannock 1
Tianjin 1
Varese 1
Verona 1
Wenzhou 1
Totale 866
Nome #
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 161
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 105
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 100
A Sorting Strategy For Bovine Mammary Progenitors 90
CD157 as a potential pleural effusion biomarker for malignant mesothelioma 89
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 86
Unraveling the potential role of autophagy in CD157-associated chemoresistance in malignant pleural mesothelioma. 83
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 80
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 78
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 78
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 66
Zoledronic acid targets tumor-associated macrophages to overcome the resistance to the anti-angiogenic therapy in a mouse model of spontaneous cervical cancer 64
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 63
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 57
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 57
Totale 1.257
Categoria #
all - tutte 3.886
article - articoli 0
book - libri 0
conference - conferenze 2.574
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020168 0 7 2 21 16 39 28 17 8 19 8 3
2020/2021143 17 16 1 5 18 14 5 6 9 14 9 29
2021/2022188 2 10 2 11 14 18 3 12 9 15 63 29
2022/2023307 27 32 12 32 31 80 20 12 28 11 15 7
2023/2024100 15 26 8 5 3 8 0 5 0 8 8 14
2024/20256 4 2 0 0 0 0 0 0 0 0 0 0
Totale 1.257